Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	211.82	222.5	286.33	28	31.34	142.09
Short-Term Investments	65.85	57.81	-	123.72	125.2	89.73
Cash & Short-Term Investments	277.67	280.32	286.33	151.72	156.54	231.82
Cash Growth	-8.31%	-2.10%	88.72%	-3.08%	-32.47%	98.71%
Accounts Receivable	95.85	78.29	67.97	23.99	3.27	-
Other Receivables	-	-	-	-	0.3	-
Receivables	95.85	78.29	67.97	23.99	3.57	-
Inventory	22.42	22.4	22.31	5.57	1.51	-
Prepaid Expenses	14.87	11.78	10.94	8.95	4.97	4.53
Total Current Assets	410.82	392.79	387.54	190.23	166.59	236.35
Property, Plant & Equipment	8.77	9.81	1.99	2.35	2.55	3.24
Long-Term Investments	20.91	12.53	-	-	4.98	-
Other Intangible Assets	243.85	249.82	252.93	58.95	18.74	-
Other Long-Term Assets	5.9	5.81	4.17	101.38	101.79	1.27
Total Assets	690.25	670.75	646.62	352.91	294.65	240.86
Accounts Payable	11.64	14.62	7.42	8.69	9.17	3.15
Accrued Expenses	64.07	72.86	54.89	34.73	24.42	13.41
Current Portion of Leases	1.64	1.71	1.1	0.93	0.71	0.64
Other Current Liabilities	50.22	37.36	23.65	20.37	8.3	1.26
Total Current Liabilities	127.58	126.55	87.06	64.73	42.6	18.46
Long-Term Debt	308.51	308.08	306.42	-	-	-
Long-Term Leases	7	7.97	0.62	1.26	1.9	2.63
Other Long-Term Liabilities	13.9	2.51	3.85	144.88	129.94	47.68
Total Liabilities	456.99	445.11	397.95	210.87	174.44	68.77
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	892.37	870.19	803.26	535.07	377.4	345.18
Retained Earnings	-658.86	-644.18	-556.24	-392.82	-257.16	-173.17
Comprehensive Income & Other	-0.26	-0.37	1.64	-0.22	-0.04	0.08
Total Common Equity	233.26	225.64	248.67	142.04	120.21	172.1
Shareholders' Equity	233.26	225.64	248.67	142.04	120.21	172.1
Total Liabilities & Equity	690.25	670.75	646.62	352.91	294.65	240.86
Total Debt	317.16	317.76	308.14	2.19	2.61	3.26
Net Cash (Debt)	-39.48	-37.45	-21.82	149.53	153.93	228.56
Net Cash Growth	-	-	-	-2.86%	-32.65%	102.24%
Net Cash Per Share	-0.82	-0.79	-0.53	4.40	5.08	9.05
Filing Date Shares Outstanding	49.53	49.01	47	37.95	31.73	30.42
Total Common Shares Outstanding	49.45	48.34	46.72	36.96	30.58	29.78
Working Capital	283.24	266.24	300.48	125.5	124	217.89
Book Value Per Share	4.72	4.67	5.32	3.84	3.93	5.78
Tangible Book Value	-10.59	-24.18	-4.26	83.08	101.47	172.1
Tangible Book Value Per Share	-0.21	-0.50	-0.09	2.25	3.32	5.78
Machinery	-	1.64	0.91	0.6	0.2	0.3
Leasehold Improvements	-	0.2	1.3	1.31	1.48	1.29

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q